Drreddys Laboratories | RDY - 应收帐款人

金融业

INR

INR 6.26B

现金及等价物

INR 18.66B

INR 40.46B

INR 3.31B

INR 1.76B

INR 67.73B

股息收益率

INR 0.65

INR 16.37B

INR 21.59B

INR 27.81K

EPS每股收益

INR 0.16

股本和储备

INR 4.14B

INR 46.81B

债务利息支出

INR 944M

INR 796M

INR 129.19M

INR 2.2B

INR 12.1B

INR 72.94B

INR 14.33B

普通股股本

INR 832.57M

18.27

INR 15.43B

INR 87.27B

销售和管理费用

INR 26.92B

INR 79.01B

贸易债权人

INR 454.04M

应收帐款人

INR 1.41B

	应收帐款人	更改		日
ANI Pharmaceuticals	USD 255.43M		25.65M	2026-03
Aurora Cannabis	CAD 48.26M		1.53M	2025-12
Bayer	EUR 14.19B		720M	2025-12
Canopy Growth	CAD 140.42M		113.56M	2025-12
Cipla	INR 74.61B		19.39B	2025-09
Corcept Therapeutics	USD 39.07M		20.71M	2026-03
Drreddys Laboratories	INR 1.41B		11.6M	2025-12
GlaxoSmithKline	GBP 7.94B		178M	2026-03
Hikma Pharmaceutical	USD 1.08B		27M	2025-12
Lonza	CHF 1.78B		55M	2025-12
Novartis	USD 9.6B		2.69B	2026-03
Pacira	USD 125.64M		1.57M	2026-03
Phibro Animal Health	USD 215.87M		2.02M	2025-12
Prestige Brands	USD 190.46M		8.54M	2025-12
Richter Gedeon	HUF 255.68B		11.17B	2025-12
Sun Pharmaceuticals	INR 157.04B		26.1B	2025-09
Supernus Pharmaceuticals	USD 182.18M		5.62M	2026-03
Teva Pharmaceutical Industries	USD 3.39B		316M	2026-03